STOCK TITAN

inTEST Corporation 8-K Filings

INTT NYSE

Every 8-K that inTEST Corporation (INTT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow INTT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INTT filings page.

Rhea-AI Summary

InTest Corporation reported that it has further amended its existing senior credit facility with M&T Bank by entering into an Eighth Amendment to the Amended and Restated Loan and Security Agreement on August 14, 2026. This amendment extends the period during which InTest may request advances under its term loan facility until August 28, 2028, effectively lengthening the time the company can draw on this borrowing capacity. The Amended Credit Agreement continues to cover InTest and several subsidiaries, including Ambrell Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc., and Alfamation US, Inc., and is attached as an exhibit for reference.

Rhea-AI Summary

InTest Corporation reported second-quarter 2026 revenue of $35.3 million, up 25.5% year-over-year and its third straight quarter of sequential growth. Growth was driven largely by Auto/EV, which represented 38.1% of revenue, while non-semiconductor markets in total contributed approximately 74% of revenue.

GAAP net earnings were $0.5 million, or $0.04 per diluted share, compared with a loss of $0.5 million a year ago. Adjusted EPS was $0.09 versus $0.03, and Adjusted EBITDA rose to $2.2 million, up 73.7% year-over-year, though Adjusted EBITDA margin was 6.2%. Gross margin declined to 40.5% from 43.3% in the first quarter, reflecting a shift toward higher-volume, lower-margin Auto/EV products.

Orders in the quarter were $28.9 million, up 4.0% year-over-year but down 9.2% sequentially, while backlog was $45.4 million, up 19.8% year-over-year and down 12.4% sequentially. Cash and cash equivalents increased to $22.1 million, aided by $6.3 million provided by operating activities and a $1.0 million term-debt reduction. Management reiterated its raised full-year 2026 revenue outlook of $135–$140 million and expects third-quarter 2026 revenue of $33–$35 million with gross margin of about 44%.

Rhea-AI Summary

InTest Corporation reported preliminary results for the quarter ended June 30, 2026 and updated its 2026 outlook. For the second quarter, revenue is expected to be approximately $35 million, gross margin approximately 40%, and operating expenses about $13.9 million, compared with prior guidance of $32 million to $34 million in revenue, around 45% gross margin, and $13.8 million to $14.2 million in operating expenses.

The company identified implementation issues with a new ERP system at its Alfamation business that led to overstated inventory and gross margin in the first quarter of 2026. Management determined that first quarter consolidated gross profit was overstated by about $750,000, requiring a 220-basis-point downward revision to previously reported Q1 gross margin. InTest plans to revise first quarter financial results and expects to report a material weakness in internal control over financial reporting, although it believes this weakness has been remediated.

For full year 2026, InTest now expects revenue of $135 million to $140 million, up from prior guidance of $130 million to $135 million, and a full year gross margin of approximately 43% versus prior guidance of 45%. Full year operating expenses are still projected at $55 million to $57 million, with an expected effective tax rate of about 18%.

Rhea-AI Summary

InTest Corporation held its 2026 Annual Meeting of Stockholders on June 17, 2026, where a quorum of 9,494,132 shares was present out of 12,548,356 shares outstanding as of the April 20, 2026 record date. Stockholders elected five directors to serve until the next annual meeting, each receiving a majority of votes cast. They also approved Amendment No. 1 to the InTest Corporation 2023 Stock Incentive Plan and ratified RSM US LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers.

Rhea-AI Summary

InTest Corporation reported strong first quarter 2026 results with revenue of $33.9 million, up 27.2% year-over-year. Gross margin improved to 45.5%, and net earnings reached $0.8 million, or $0.06 per diluted share, compared with a loss a year ago. Non-GAAP adjusted EPS was $0.16 and adjusted EBITDA was $3.2 million, reflecting better volume, product mix and cost control.

Orders were $31.8 million, up 25.4% year-over-year, and backlog grew to $51.8 million, 35.5% higher than a year earlier. The company raised full-year 2026 revenue guidance to $130 million–$135 million and now expects about 45% gross margin and operating expenses of $55 million–$57 million. In a separate move, InTest amended its loan agreement with M&T Bank, extending the period to draw on its term loan facility to August 28, 2026.

Rhea-AI Summary

InTest Corporation reported that Director Gerald J. Maginnis, who chairs the Audit Committee and serves on the Compensation and Nominating and Corporate Governance Committees, plans not to stand for re-election at the Company’s 2026 annual meeting of shareholders.

Maginnis will continue serving on the Board and its committees until the 2026 annual meeting. The Company stated that his decision is for personal reasons, including other professional commitments, and is not related to any disagreement regarding InTest’s operations, policies, or practices.

Rhea-AI Summary

InTest Corporation announced that Richard N. Grant, Jr. has stepped down as President, Chief Executive Officer and director, effective immediately, in accordance with his 2020 offer letter and not due to any disagreement over operations, policies or practices. He is eligible for severance equal to 12 months of base salary, conditioned on signing a separation and release agreement.

The Board appointed Richard Rogoff, previously Vice President of Corporate Development, as President, CEO and director effective March 31, 2026. Under a new agreement, he will receive a $375,000 annual base salary, a 2026 target bonus equal to 65% of base salary, and performance-vesting stock options for up to 300,000 shares with a 10-year term, vesting based on share price performance over a three-year period.

Rhea-AI Summary

inTEST Corporation detailed 2026 compensation decisions for its President and CEO, Richard N. Grant, Jr., and its CFO, Treasurer and Secretary, Duncan Gilmour. Their base salaries will remain at 2025 levels of $428,915 for the CEO and $282,500 for the CFO.

The Compensation Committee set short-term performance bonus targets for 2026 at 85% of base salary for the CEO and 65% for the CFO, with actual payouts ranging from zero to above target depending on 2026 performance. The Committee also approved long-term incentive awards with grant date fair values of $600,000 for the CEO and $250,000 for the CFO, split equally among four-year time-vesting stock, a three-year performance-vesting award, and stock options.

The equity grants will be made on the second business day after the company files its 2025 Form 10-K, with options and time-based awards vesting in equal annual installments over four years. Performance-vested awards will cliff-vest after the period ending December 31, 2028, based on the company’s enterprise value as determined by the Compensation Committee, and all awards are issued under the inTEST Corporation 2023 Stock Incentive Plan.

Rhea-AI Summary

InTest Corporation reported fourth quarter 2025 revenue of $32.8 million and diluted EPS of $0.10, with gross margin improving to 45.4% and nearly 80% of revenue from non-semiconductor markets. Orders were $37.5 million and year-end backlog reached $53.9 million, up 36.4% from a year earlier.

For full year 2025, revenue declined 12.9% to $113.8 million and the company moved from net earnings of $2.9 million in 2024 to a net loss of $2.5 million, or ($0.21) per diluted share. Adjusted EBITDA fell to $4.0 million from $10.8 million. Management reduced total debt by $7.6 million during 2025 and ended the year with $18.1 million in cash, cash equivalents and restricted cash.

Looking ahead, InTest targets 2026 revenue between $125 million and $130 million, gross margin of about 45%, and operating expenses of $53 million to $55 million. First quarter 2026 revenue is projected at $31 million to $33 million with gross margin of roughly 44%, supported by a stronger backlog and expected recovery in semiconductor demand in the second half.

Rhea-AI Summary

inTEST Corporation (INTT) furnished a Form 8-K announcing it issued a press release with financial results for the third quarter ended September 30, 2025. The disclosure appears under Item 2.02, Results of Operations and Financial Condition.

The information provided under Item 2.02, including Exhibit 99.1 (2025 Third Quarter Results Press Release dated November 5, 2025), is furnished and not deemed “filed” for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into other filings.

Rhea-AI Summary

inTEST (NYSE: INTT) filed an 8-K disclosing the voting results of its 2025 Annual Meeting held on June 18, 2025.

Shareholders re-elected all five director nominees, ratified RSM US LLP as independent auditor, and approved the company’s 2024 executive compensation on an advisory basis. Support levels were high—each director received at least 86 % of votes cast; the auditor garnered nearly 99 %.

Investors also indicated a preference for an annual say-on-pay vote (86.7 % in favor). No proposals were rejected, and no other material business items were introduced.